About Heart defect-tongue hamartoma-polysyndactyly syndrome
Heart defect-tongue hamartoma-polysyndactyly syndrome is a rare disease catalogued by Orphanet (ORPHA:1338). It is associated with the WDPCP gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Heart defect-tongue hamartoma-polysyndactyly syndrome trials.
Search ClinicalTrials.gov for "Heart defect-tongue hamartoma-polysyndactyly syndrome" or filter by Orphanet code ORPHA:1338 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Heart defect-tongue hamartoma-polysyndactyly syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Heart defect-tongue hamartoma-polysyndactyly syndrome. Updated daily.